| Company Name |
Cohance Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
543064 |
| Year End |
202503 |
| Full Year |
| Equity (Rs.Cr.) |
38.26 |
| B.V. Rs. |
115.30 |
| Sales Rs. Cr. |
1,093.51 |
| NP Rs. Cr. |
271.77 |
| NP Var% |
-8.00 |
| Div% |
0.00 |
| CPS Rs. |
8.60 |
| EPS Rs. |
7.10 |
| Traded Value(Rs.Lakhs) |
103.05 |
| 52 Week High |
1,328.00 |
| 52 Week Low |
521.00 |
| Price BSE |
537.00 |
| Price NSE |
536.00 |
| Market Capital(Rs. Cr.) |
20,524.73 |
| P/C Ratio |
62.40 |
| P/E Ratio |
75.60 |
| Price Vs.BV |
4.66 |
| Year End |
202509 |
| Sales Rs. Cr. |
497.79 |
| NP Rs. Cr. |
94.29 |
| NP Var % |
-32.00 |
| Year End |
202509 |
| Sales |
914.50 |
| OPM |
38.18 |
| NP |
247.20 |
| NP Var% |
15.89 |
| EPS |
9.70 |
| PE |
55.31 |
|
|